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Background: To quantify the development of radiation neuropathy in corneal subbasal nerve plexus (SNP) after
plaque brachytherapy, and the subsequent regeneration of SNP micromorphology and corneal sensation.
Methods: Nine eyes of 9 melanoma patients (ciliary body: 3, iris: 2, conjunctiva: 4) underwent brachytherapy
(ruthenium-106 plaque, dose to tumour base: 523 ± 231 Gy). SNP micromorphology was assessed by in-vivo
confocal microscopy. Using software developed in–house, pre-irradiation findings were compared with those
obtained after 3 days, 1, 4 and 7 months, and related to radiation dose and corneal sensation.
Results: After 3 days nerve fibres were absent from the applicator zone and central cornea, and corneal sensation
was abolished. The earliest regenerating fibres were seen at the one-month follow-up. By 4 months SNP structures
had increased to one-third of pre-treatment status (based on nerve fibre density and nerve fibre count), and
corneal sensation had returned to approximately two-thirds of pre-irradiation values. Regeneration of SNP and
corneal sensation was nearly complete 7 months after plaque brachytherapy.
Conclusions: The evaluation of SNP micromorphology and corneal sensation is a reliable and clinically useful
method for assessing neuropathy after plaque brachytherapy. Radiation-induced neuropathy of corneal nerves
develops quickly and is partly reversible within 7 months. The clinical impact of radiation-induced SNP damage is
moderate.
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Plaque brachytherapy is an established modality in the
treatment of uveal and conjunctival melanoma. While
iodine-125 and ruthenium-106 (Ru-106) have each been
used for plaque brachytherapy [1-5], the advantages of
plaques containing Ru-106 as a beta-emitter include a fi-
nite range of radiation [6]. Various ophthalmological
complications following Ru-106 irradiation have been
reported in series of patients with malignant uveal mel-
anoma [5,7]. Summanen et al. [7] investigated radiation-
related complications in 100 eyes, including 38 with* Correspondence: andyzhyvov@yahoo.com
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reproduction in any medium, provided the oranterior melanoma location (at least partly anterior to
the equator, with or without ciliary body involvement).
At follow-up after 2 years the probability of developing
complications was reported as follows: radiation
maculopathy 15%, optic neuropathy 10%, vitreous haem-
orrhage 9%, secondary (neovascular) glaucoma 4%, and
radiation cataract 21%, depending on tumour location.
We are not aware of any studies that have investigated
corneal sensation problems as well as changes in the mi-
cromorphology of the corneal subbasal nerve plexus
(SNP) as signs of radiation neuropathy.
Confocal laser scanning microscopy permits in-vivo
investigation of tissue in the healthy and pathological
cornea. The normal structure of the SNP and its physio-
logical dynamic changes over time have already been
studied [8-10]. Similarly, postoperative changes in theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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corneal grafting [11-13] and refractive surgery [11,14],
and have been correlated with corneal sensation. Re-
cently, the development of small-fibre neuropathy has
been investigated using confocal microscopy in diabetic
patients [15,16] and in those with Fabry disease [17].
Our group has established 3-dimensional image recon-
struction of the cornea, as well as real-time mapping of
large-scale 2-dimensional images of the SNP [18]. This
methodology permits the quantitative analysis of corneal
nerve structures by confocal microscopy [19].
The aim of the present study was to investigate and
quantify the degeneration and regeneration of fibres of
the corneal SNP after Ru-106 plaque brachytherapy, and
to relate these to corneal sensation changes.Methods
This prospective case series study was conducted after a
positive appraisal by the local ethics Board of Medical
Faculty, University of Rostock, Germany. The research
adhered to the tenets of the Declaration of Helsinki. The
study was explained in detail to the patients, and in-
formed consent was obtained before any investigative
procedures were conducted. The inclusion criteria were
absence of current or previous local or systemic disease
that could affect the cornea, and a negative history of
ocular infections, eye surgery or trauma.
The study was conducted in 9 eyes (3 with ciliary body
melanoma, 2 with melanoma of the iris, and 4 with malig-
nant conjunctival melanoma) of 9 patients (aged 61.0 ±
12.1 years; 6 female, 3 male). All patients underwent
brachytherapy with an Ru-106 ophthalmic plaque (BEBIG
GmbH, Berlin, Germany). Demographic data as well as
clinical and dosimetric information are presented in












1 F 73 conjunctiva 0.5 4.30
2 M 65 conjunctiva 7.0 4.64
3 F 46 iris 2.0 5.00
4 F 50 iris 3.0 5.09
5 F 76 ciliary body 3.6 4.94
6 F 40 conjunctiva 1.0 7.79
7 F 66 ciliary body 5.0 9.54
8 M 61 ciliary body 1.2 7.17
9 M 73 conjunctiva 2.3 4.87
Mean +/−SD 5.9+/In order to simulate the radiation level in the cornea
an isodose curve plot for the Ru-106 plaque was created
using ‘Plaque Simulator’ Software (BEBIG GmbH, Berlin,
Germany). The cornea was divided into three areas
(each approximately one-third of the corneal diameter):
(A) the applicator zone (the cornea directly beneath the
plaque); (B) the central zone (equivalent to the central
third of the cornea); and (C) the distal zone (the peripheral
cornea distant from the applicator zone) (Figure 1a, b).
The structures of the SNP are located in the cornea at a
depth of 55–70 μm, and therefore the dose calculation was
performed as for the corneal surface. The dose in the cen-
tral axis of the cornea to the tumour base in the applicator
zone differed between patients depending on melanoma
size (see Table 1), ranging from 278 to 1070 Gy with a
mean value of 522 Gy, a median dose of 520 Gy, and a
mean dose rate of 5.9 Gy/h. The isodose plot shows that
the applicator zone has about 100% of the tumour base
dose (522 Gy), the corneal surface directly adjacent to the
plaque 0.44% (2.29 Gy), the surface of the central third of
the cornea a mean of 0.12% (0.63 Gy) and the distal zone
0.015% (0.08 Gy) (Figure 1c). The individual prescribed
dose to the tumour base as well as the calculated doses in
each corneal zone are presented in Table 1.
In-vivo confocal microscopy of SNP structures and as-
sessments of corneal sensation were performed before
irradiation, and at 3 days and 1, 4 and 7 months after
therapeutic intervention.
In-vivo confocal microscopy with a Rostock Cornea
Module (RCM) in combination with a Heidelberg Retina
Tomograph II (Heidelberg Engineering, Heidelberg,
Germany) equipped with a water contact objective
(Zeiss, 63×/0.95 W, 670 nm, ∞/0, Jena, Germany) was
performed as described elsewhere [20]. Image acquisi-
tion of the central axis of the cornea in the applicator,












Central zone Distal zone
278 1.22 0.33 0.04
293 1.29 0.35 0.04
550 2.42 0.66 0.08
520 2.29 0.62 0.08
527 2.31 0.63 0.08
387 1.7 0.46 0.06
1070 4.7 1.28 0.16
500 2.20 0.60 0.08
573 2.52 0.69 0.09















Figure 1 Clinical situation and isodose distribution by Ru-106 brachytherapy. (a) Schematic diagram of the corneal zones: applicator zone
(A), central zone (B) and distal zone (C), each representing approximately one-third of the corneal vertical diameter. Note that vertical diameter of
the cornea is approx. 10.5 mm, and the horizontal diameter 11.5 mm. (b) Photograph of a patient’s eye during brachytherapy: the Ru-106 plaque
is located in the upper third of the cornea. (c) Diagram of isodose distribution: Simulation of CCB plaque with a dose of 522 Gy to the tumour
base. The directly adjacent cornea receives 2.29 Gy (0.44% isodose), the central zone 0.63 Gy (0.12%) and the distal zone 0.08 Gy (0.015%) over
the entire time course of plaque brachytherapy.
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http://www.ro-journal.com/content/8/1/136automatic volume scan mode (30 images, volume depth
60 μm, constant interslice distance 2 μm, 384 × 384
pixels, 400 × 400 μm). Acquisition time for a single stack
was 1.2 s. Confocal microscopy was performed in the re-
gion of interest, i.e. at the level of basal cells, SNP,
Bowman’s membrane and anterior stroma at depths
from 30 to 90 μm. At least three scans were performed
in each zone. The total duration of microscopy was
about 15 minutes.
Automatic detection and quantification of SNP struc-
tures based on morphological and topological parame-
ters was performed on the basis of an algorithm
developed in-house. Image analysis was carried out in
two stages. Firstly, the segmented images were analysed
morphologically and after this step the fibres wereskeletonised in order to obtain their one pixel wide med-
ial axis. In a second stage the topological analysis of the
medial axis network took place. Consequently the main
parameters were split up into two main categories: (1)
before skeletonisation (component pixels) and (2) after
skeletonisation (number of nerve fibre components,
skeleton pixels, single nerve fibres per component, total
fibre length, average single fibre length, nerve fibre
density, connectivity points, and number of branches)
(Table 2). All measured variables can be used in isolation,
combined or weighted for quantification of SNP networks.
Representative images of the SNP as well as segmentation
and analysis of the SNP are shown in Figure 2.
Corneal sensation was evaluated with a Cochet-Bonnet
aesthesiometer (Luneau Ophthalmologie, Chartres Cedex,
Table 2 Parameters used for automatic quantification of SNP structures
Component pixels number of pixels identified as nerve fibres
Nerve fibre components number of separate nerve fibre networks
Skeleton pixels number of pixels representing the medial axes of nerve fibres
Single nerve fibres number of all nerve segments between nerve branches and nerve ends
Total nerve fibre length/average single nerve fibre length length of all nerve fibres in the image area/average length of single nerve fibres
Nerve fibre density length of all fibres in respect to 1 mm2
Number of connectivity points number of nerve fibres entering or leaving the image area to the outside
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http://www.ro-journal.com/content/8/1/136France; diameter of monofilament 12/100). The filament
was applied along its full 60 mm length; if the response
was negative the filament length was then reduced in
5 mm steps. Sensation was tested in each region of the
cornea, and normal sensation was defined as between 50
and 60 mm.
Results
Before irradiation, the SNP displayed a typical pattern
with hyperreflective fibres, regular tortuosity and nerve
branching (Figure 3a-c). Three days after brachytherapy,
no subbasal nerve fibres were visualised in the applicator
zone or in the central zone (Figure 3d, e) and very few
in the distal zone (Figure 3f ). The earliest regenerating
nerve fibres were detected at the one-month follow-up
after therapeutic intervention: SNP structures were
present in the whole cornea, although less branching
and tortuosity were seen in the applicator zone and the
central zone (Figure 3g, h). Four months postoperatively
SNP structures had increased to almost one-third com-
pared with the pre-irradiation status (Figure 3j, k). In
qualitative terms SNP morphology had returned to ini-
tial status by seven months after plaque brachytherapy
(Figure 3m, n).a
Figure 2 Imaging and automated quantification of SNP. (a) Representa
plaque brachytherapy). (b) Results of automated image segmentation and analy
single nerve fibre count (n) 19. Image size: 400 x 400 μm.Table 2 defines and Table 3 presents the quantitative
data on micromorphological SNP variables before irradi-
ation and during follow-up. In order to illustrate the
most representative data as nerve fibre density (NFD,
mm/mm2) and number of single nerve fibres (SNF, n,
normalised to an area of 1 mm2) are reported in detail
below.
NFD (Figure 4a): the applicator zone was characterised
by a decrease in NFD to 5% of pre-irradiation density at
3 days after therapeutic intervention, followed by post-
therapeutic regeneration to 26%, 31% and 85% at 1, 4
and 7 months respectively. A similar pattern was found
for the central zone: a decrease to 4% at 3 days with sub-
sequent post-therapeutic increases in NFD to 37%, 33%
and 71% at 1, 4 and 7 months respectively. Interestingly,
the distal zone also showed a reduction in NFD to 27%
at 3 days after therapeutic intervention, followed by re-
generation to 54%, 73% and 91% at 1, 4 and 7 months
respectively.
SNF (Figure 4b): the applicator zone showed a de-
crease in SNF to 2% at 3 days after therapeutic interven-
tion, followed by a slow recovery to 16%, 17% and 78%
at 1, 4 and 7 months respectively. The central zone was
characterised by an initial reduction in SNF to 3% atb
tive in-vivo confocal image of the corneal SNP (distal zone, 4 months after




















































Figure 3 Representative in-vivo confocal images of the corneal SNP of patients over time. Image size: 400 × 400 μm. Each image also
shows data on corneal sensation (in mm).
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http://www.ro-journal.com/content/8/1/1363 days, with subsequent rises to 22%, 41% and 50% at 1,
4 and 7 months respectively. The distal zone revealed a
decrease to 29% at 3 days followed by an increase to
78% at 1 month. At 4 and 7 months after therapeutic
intervention there was regeneration of SNF to 108% and
117% respectively.
Corneal sensation (Figure 4c): pre-irradiation corneal
sensation was 58 ± 4 mm in all zones. After therapeutic
intervention, corneal sensation in the applicator zone
was markedly reduced, being 5 ± 6 mm at 3 days, and in-
creasing to 23 ± 15 mm at 1 month, 39 ± 17 mm at4 months, and 56 ± 4 mm at 7 months. The pattern of
corneal sensation findings at the corresponding time
points was 8 ± 6 mm, 23 ± 17 mm, 41 ± 19 mm and 57 ±
5 mm in the central zone; and 23 ± 12 mm, 37 ± 17 mm,
50 ± 18 mm and 54 ± 17 mm in the distal zone.
Discussion
Cancer-related neuropathy is a serious complication
resulting from nerve damage caused by a malignancy or
its treatment [21]. A number of authors have evaluated
different forms of neuropathy, most commonly describing
Table 3 Results of automated quantification of SNP variables before and after brachytherapy (all normalised to an













Component pixels (n) Applicator 45050.0 ± 23273.0 2031.3 ± 2637.8 11714.1 ± 12851.5 14118.8 ± 7941.5 38592.5 ± 25383.8
Central 42589.6 ± 16506.1 1552.1 ± 2688.3 15663.8 ± 15369.3 14048.4 ± 7681.3 30116.7 ± 18365.5
Distal 41421.3 ± 6598.9 11056.3 ± 6637.8 21918.8 ± 21252.3 30116.7 ± 24992.7 37814.6 ± 18680.4
Total number of nerve
fibre components (n)
Applicator 50.0 ± 34.7 4.2 ± 3.6 23.4 ± 16.4 31.3 ± 22.8 53.8 ± 26.0
Central 52.1 ± 25.5 2.1 ± 3.6 15.0 ± 13.0 12.5 ± 5.1 66.7 ± 36.1
Distal 50.0 ± 40.3 25.0 ± 22.5 14.1 ± 16.4 22.9 ± 7.2 70.8 ± 18.0
Skeleton pixels (n) Applicator 13715.6 ± 7004.1 622.9 ± 809.2 3456.3 ± 3774.2 4300.0 ± 2411.0 11622.5 ± 7566.4
Central 12876.0 ± 5053.8 460.4 ± 797.5 4627.5 ± 4483.7 4217.2 ± 2308.7 9110.4 ± 5497.3
Distal 12722.5 ± 1979.2 3347.9 ± 2056.2 6585.9 ± 6253.7 9077.1 ± 7387.1 11422.9 ± 5671.4
Single nerve fibres (n) Applicator 240.6 ± 184.0 4.2 ± 3.6 37.5 ± 39.9 40.6 ± 25.8 188.8 ± 133.4
Central 235.4 ± 167.5 6.3 ± 10.8 51.3 ± 68.4 96.9 ± 112.9 116.7 ± 85.1
Distal 162.5 ± 84.7 47.9 ± 28.2 126.6 ± 127.5 175.0 ± 197.3 189.6 ± 108.7
Average single fibre
length (μm)
Applicator 83.4 ± 34.3 166.4 ± 154.1 101.1 ± 52.4 147.3 ± 77.4 74.2 ± 13.5
Central 74.4 ± 31.2 84.3 ± 0 151.9 ± 65.7 83.8 ± 46.1 89.2 ± 19.4
Distal 100.2 ± 37.8 93.5 ± 60.7 61.1 ± 7.9 74.4 ± 22 68.8 ± 7.2
Nerve fibre density
(mm/mm2)
Applicator 15.142 ± 7.93 0.693 ± 0.908 3.896 ± 4.315 4.713 ± 2.638 12.945 ± 8.586
Central 14.207 ± 5.553 0.527 ± 0.913 5.322 ± 5.205 4.736 ± 2.538 10.031 ± 6.221
Distal 13.827 ± 2.279 3.725 ± 2.302 7.471 ± 7.278 10.151 ± 8.627 12.643 ± 6.348
Connectivity points (n) Applicator 14.2 ± 10.4 0 ± 0 1.3 ± 2.5 5.6 ± 6.6 13 ± 11.5
Central 14.2 ± 6.5 0 ± 0 2.0 ± 3.3 1.3 ± 2.5 13.3 ± 10.4
Distal 13.0 ± 9.6 1.7 ± 1.4 5.6 ± 6.6 8.3 ± 8.8 12.5 ± 9.0
Branches (n) Applicator 104.2 ± 91.8 0 ± 0 7.8 ± 15.6 4.7 ± 6.0 73.8 ± 64.1
Central 101.0 ± 101.6 2.1 ± 3.6 18.8 ± 35.1 45.3 ± 59.2 25.0 ± 33.1
Distal 61.3 ± 43.6 12.5 ± 16.5 62.5 ± 61.0 87.5 ± 120.5 58.3 ± 54.6
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neuropathy, resulting in radiculopathies, back pain, head-
aches, paraesthesia, etc. [22,23]. Previous experimental
animal studies have disclosed radiation-induced changes
in the rabbit sciatic nerve, e.g. vacuolation, degeneration
and necrosis of axons with myelin fragmentation [24].
This and most other clinical and experimental studies
have focused on radiation effects on myelinated nerves
and nerve fibres. However, the mechanisms underlying
degeneration and regeneration of myelinated and unmy-
elinated nerves may be different.
To our knowledge no clinical study has yet investigated
the neuropathy affecting unmyelinated corneal nerves
after brachytherapy. Previous studies on radiation damage
in the eye have addressed neuropathy of the optic nerve as
well radiation retinopathy, maculopathy, cataracts, vitre-
ous haemorrhage or secondary glaucoma after plaque
therapy [7] and external beam radiotherapy [25].
Several studies have described degeneration of SNP
structures in diabetes mellitus [16,26,27] or Fabrydisease [17,28]. Regeneration of SNP has also been
assessed after refractive surgery [29] and corneal grafting
[13], procedures that were also associated with periph-
eral neuropathies. Our study demonstrates that even low
radiation doses such as those received by the central
zone lead to rapid but reversible degeneration of the
SNP in the cornea.
Degeneration of nerve structures, characterised by
complete absence of subbasal nerve fibres, was evident
in the applicator zone and central zone directly after
plaque brachytherapy. The first thin regenerating fibres
of SNP were seen at the one-month follow-up, and by
4 months after therapeutic intervention SNP structures
had increased to about one-third of pre-irradiation sta-
tus (based on nerve fibre density and number of nerve
fibres). While almost complete SNP regeneration was
noted at 7 months after the intervention, the micromor-
phology of the nerve fibres in all zones irrespective of
the local radiation dose was still quantitatively altered





































Figure 4 Automated quantification of SNP structures and
corneal sensation over time (percentage changes compared
with pre-irradiation level): (a) Automated quantification of nerve
fibre density. (b) Automated quantification of single nerve fibres.
(c) Corneal sensation.
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regeneration, showed a direct correlation with the
changes in corneal sensation recorded during follow-up
in the present study. Sensation in the applicator zone
was reduced to below 10% of pre-irradiation values at
3 days after the intervention, before increasing again to
about 67% at 4 months and 96% at 7 months (Figure 4c).
Post-irradiation corneal sensation in the distal zone was
about 40% at 3 days, 86% at 4 months and 93% at
7 months. These findings strongly suggest that the local
biological radiation damage is not related to the localdose but rather reflects a particular form of bystander
radiation damage. The entire SNP network responds as
one biological structure with little difference between
high-dose areas and low-dose areas.
The radiation doses in the central cornea as well as in
the distal zone are obviously very low. Similar doses are
encountered in external beam radiotherapy of head and
neck cancers, and yet no impairment of corneal sensa-
tion has ever been reported. Therefore we presume that
the decrease in SNP density might be induced as a result
of radiation damage to the nerve fibre network directly
in the applicator zone. Since the central part of the SNP
originates from collaterals of the SNP in the periphery
as well as from the sub-Bowman’s nerves of anterior
stroma [30], we postulate that the damage to nerves in
the central and distal zones is due to the disruption of
the complex collateral 3-dimensional organisation of
SNP.
One limitation of our study is the 1 μm lateral reso-
lution of in-vivo confocal microscopy. This means that
nerve structures below 1 μm were not detected, thus ac-
counting for some discrepancy of findings. A possible
way forward might be 3-dimensional reconstruction of
the image with resultant extraction of SNP structures
and subsequent automated analysis [31]. Moreover, in
follow-up investigations of corneal surfaces which re-
ceive vastly different radiation doses, microscopy of a
larger area would be useful. New developments of tech-
nology permit mapping of the cornea with a maximum
image size of 3072 × 3072 pixels (3.2 × 3.2 mm) [18].
Several pathogenic pathways and manifestations of
corneal neuropathy can be distinguished: (i) mechanical
damage to corneal nerves after corneal grafting; (ii) mech-
anical or laser-induced flap preparation during laser in-
situ keratomileusis (LASIK); (iii) mechanical abrasion and
laser treatment procedures during photorefractive keratec-
tomy (PRK); and (iv) UVA light and riboflavin exposure.
Neuropathy after corneal grafting was reported in
histochemical studies by Tervo et al.: regeneration of
SNP and stromal nerves was still incomplete as late as
36 months after surgery [32]. Ruben et al. showed that
about one-third of operated corneas were still ‘clinically
anaesthetic” (≤ 20 mm) 6 years postoperatively and an-
other one-third showed reduced corneal sensation [33].
Furthermore, the regenerated nerves were thinner and
had abnormally curved branches; also the structures
with a whorl-like pattern were absent.
SNP structures after LASIK display the same micro-
morphological pattern as after corneal grafting. While
the earliest regenerating nerves were detected 1 month
postoperatively, morphologically complete regeneration
was still not evident after 2 years. Subbasal nerve fibre
density after LASIK has been reported to be reduced by
51%, 35% and 34% at 1, 2 and 3 years respectively [34].
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SNP in the central 6 mm of the cornea and no mechan-
ical flap with intact hinge zone) subbasal nerve fibre
density was reduced by 59% at 1 year compared with
preoperative status. By 2 years subbasal nerve fibre dens-
ity was virtually unchanged from preoperative values,
and remained constant over the next 3 years of follow-
up [34]. Our own group has demonstrated that corneal
sensation returns to 90% of normal values by about
12 months postoperatively. However, other studies have
described delayed recovery of corneal sensation over pe-
riods ranging from 3 weeks to 9 months [11].
Another example of SNP damage is that which results
from collagen cross-linking (exposure to riboflavin and
UVA light): the mechanism responsible for corneal neur-
opathy in that setting remains unclear. Nerve branches
are reportedly absent immediately postoperatively, while
the first isolated nerves have been noted from 3 months
onwards [35] and have ‘regenerated’ by 6 months after
cross-linking [36].
Taken together, different mechanisms of nerve damage
after therapeutic intervention lead to a decrease in nerve
fibre density and a resultant reduction in corneal sensa-
tion. Regenerated nerves are characterised by fewer
branches and greater tortuosity. The recovery of corneal
sensation correlates not only with the number of nerve
fibres but with the presence and number of collaterals.
Our study demonstrates that radiation-induced neur-
opathy of corneal nerves develops quickly after plaque
brachytherapy and is partly reversible within 7 months.
The SNP network responds not locally, but as an inter-
active biological system, both with regard to damage
expansion into low-dose areas and regeneration into
high-dose areas. Further studies will be needed to inves-
tigate the dependence of degeneration and regeneration
on local dose and dose inhomogeneity. As a positive
conclusion it can be stated that the clinical impact of
radiation-induced SNP damage is moderate.
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